The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease
AUTOR(ES)
Ghobadifar, Mohamed Amin, Kalani, Navid, Gitiforouz, Marzieh, Mosallanejad, Zahra
FONTE
Rev. Soc. Bras. Med. Trop.
DATA DE PUBLICAÇÃO
2014-10
RESUMO
Documentos Relacionados
- Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
- Cardiomyocyte dysfunction during the chronic phase of Chagas disease
- Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina
- Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
- Pharmacotherapeutic follow-up of patients with Chagas disease using benznidazole: drug-related problems and pharmaceutical interventions